Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell–Depleted Patients

Twenty-five B-cell–depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharbharan, Arvind, GeurtsvanKessel, Corine H, Jordans, Carlijn C E, Blaauw, Marc, van der Klift, Marjolein, Hassing, Robert-Jan, Smits-Zwinkels, Marijn, Meertens, Maaike, van den Hout, Ella C, de Man, Anne Marie, Hageman, Ilse, Bogers, Susanne, van der Schoot, C Ellen, Swaneveld, Francis, Anas, Adam A, Rokx, Casper, Rijnders, Bart J A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406883/
https://www.ncbi.nlm.nih.gov/pubmed/34293119
http://dx.doi.org/10.1093/cid/ciab647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406883/
https://www.ncbi.nlm.nih.gov/pubmed/34293119
http://dx.doi.org/10.1093/cid/ciab647

Ejemplares similares